Last reviewed · How we verify
NCT06001450: PLANET
Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
trial in Crohns Disease in 46 participants. Currently enrolling.
31 October 2026
Quick facts
| Lead sponsor | Icahn School of Medicine at Mount Sinai |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 46 |
| Start date | 15 August 2023 |
| Primary completion | 31 October 2026 |
| Estimated completion | 31 August 2027 |
| Sites | 1 location across United States |
Conditions studied
- Crohns Disease — all drugs for Crohns Disease →
- Pregnancy — all drugs for Pregnancy →
- Inflammatory Bowel Disease — all drugs for Inflammatory Bowel Disease →
Sponsor
Icahn School of Medicine at Mount Sinai
Who can join
18 and older, any sex, with Crohns Disease or Pregnancy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The PLANET Study aims to determine the impact of microplastics on intestinal inflammation and gut microbiome in order to understand the role of this pollutant on the risk of developing inflammatory bowel disease (IBD) as well as other diseases. With this information, the researchers hope to characterize better the role of environmental pollutants on IBD and develop novel strategies towards prevention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06001450
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Crohns Disease
Currently open trials in the same condition.
- NCT07338565 — Magnesium in Gastrointestinal Disease · recruiting
- NCT06721962 — Treatment of Moderate to Severe Refractory Crohn's Disease · Phase 1, PHASE2 · recruiting
- NCT06890637 — A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Crohn Diseas · NA · recruiting
- NCT06663332 — A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants · Phase 3 · recruiting
- NCT06670638 — Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Pe · recruiting
Other Icahn School of Medicine at Mount Sinai trials
Trials by the same sponsor.
- NCT07094308 — The LIFT-ECHO Last Mile Project · NA · not yet recruiting
- NCT07291427 — Chronic Subdural Hematoma Embolization With Detachable Coils · not yet recruiting
- NCT07194187 — High Intensity Focused Ultrasound (HIFU) Ablation for Treatment of Prostate Tissue in Bladder Outlet Obstruction · NA · not yet recruiting
- NCT07260916 — Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation · NA · not yet recruiting
- NCT07487948 — Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06001450 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Icahn School of Medicine at Mount Sinai
- Last refreshed: 7 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06001450.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing